Study2015Open access

Pterostilbine, an active component of blueberries, sensitizes colon cancer cells to 5-fluorouracil cytotoxicity

Tolba MF, Abdel-Rahman SZ

Scientific reports · 42 citations

Review labels

Funding not disclosedMechanisms only

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
In vitro/mechanistic study (classified by our AI screen)
Studied in
Cells or lab samples
Main outcome
Mechanisms only

Who paid for it

Funding
Funding not disclosed

Publication

Published
2015-10-16 · Sci Rep · vol. 5 · issue 1 · p. 15239
Publisher
Nature Portfolio
Cited
55 citations · more than 91% of similar papers · 2.7× the field average
Impact
Top 10% most cited in its field
References
55 works
Access
Open access (journal) · CC-BY
Research areas
FOXO transcription factor regulation · Plant tissue culture and regeneration · PI3K/AKT/mTOR signaling in cancer
Keywords
Colorectal cancer, Cytotoxic T cell, Caco-2, Cytotoxicity, Cancer research, Apoptosis, Fluorouracil, Cancer cell, Toxicity, Chemistry, Protein kinase B, Pharmacology, Medicine, Cancer, Internal medicine, Cell, Biochemistry, In vitro
MeSH
caco-2 cells, hct116 cells, humans, colonic neoplasms, stilbenes, fluorouracil, mitogen-activated protein kinase 1, mitogen-activated protein kinase 3, estrogen receptor beta, antineoplastic agents, apoptosis, binding sites, catalytic domain, phosphorylation, drug synergism, cyclin-dependent kinase inhibitor p27, proto-oncogene proteins c-akt, forkhead transcription factors, cell cycle checkpoints, molecular docking simulation, blueberry plants, forkhead box protein o1

2 authors

From EG, US

  • Mai Fathy TolbaAin Shams University; American University in Cairo
  • Sherif Z. Abdel‐RahmanThe University of Texas Medical Branch at Galveston

Abstract

Although colorectal cancer (CRC) treatment with 5-fluorouracil (5-FU) is the first line of therapy for this debilitating disease, treatment effectiveness is often hampered by the development of drug resistance and toxicity at high doses. ER-β can play an important role in CRC development and possibly in its response to therapy. Pterostilbene (PT) possesses antioxidant and anticancer effects that are mediated by ER-β. In the current study, we test the hypothesis that PT sensitizes colon cancer cells to 5-FU and we examine the underlying mechanism(s) by which PT exerts its cytotoxic effects in CRC cells. Our data indicate that PT exhibited a more potent cytotoxic effect in Caco-2 compared to HCT-116 cells. PT/5-FU co-treatment was more effective in Caco-2 cells. Our data indicate that ER-β is expressed at higher levels in Caco-2 cells and its levels are further boosted with PT treatment. PT significantly suppressed Akt and ERK phosphorylations, and enhanced FOXO-1 and p27(kip1) levels in Caco-2 cells. PT also induced a significant increase in Caco-2 cells at pre-G phase coupled with increased Bax/Bcl-2 ratio and PARP cleavage. These results provide a rationale for novel combination treatment strategies, especially for patients with 5-FU-resistant tumors expressing ER-β protein.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.